- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02907112
Impact of Reducing Dietary Intake of Red and Processed Meat Intake on Fasting Lipemia in Healthy Participants (ELM)
Studieöversikt
Detaljerad beskrivning
In UK adults, meat provides approximately 40% of the average daily protein intake and makes a significant contribution to intake of thiamin, niacin, vitamin B12, iron, zinc, potassium, and phosphorus. However, excessive consumption, particularly of red and processed meat, is associated with increased risk of developing a range of chronic diseases, including cardiovascular disease (CVD), obesity, type 2 diabetes and some cancers. Meat production significantly contributes to the production of greenhouse gasses (GHG) and hence global warming. Given the predicted global increase in the human population, coupled with the rise in demand for meat within emerging economies, it has been suggested that concerted efforts should be made to alter dietary patterns and reduce meat intake. Moreover, a number of reports have suggested that replacing meat with non-meat protein-rich products has health benefits. Such products tend to be inherently lower in total and saturated fat and, higher in fibre and as such, could also be cardioprotective.
The aim of this trial will be to investigate whether, with appropriate non/reduced-meat alternatives and motivational support, free living subjects can significantly reduce their meat intake and whether such dietary changes positively impact on a range of cardiovascular risk factors.
Trial design; A non-randomised, single group study design, with an initial control period will be used.
Participants; Forty healthy men and women will be recruited from the general population of Nottinghamshire, UK. All participants will attend the David Greenfield Human Physiology Unit (Queen's Medical Centre, Nottingham, UK) for an initial medical screening visit to confirm health status. In addition, blood pressure (BP) will be measured at the left upper arm (after lying semi-supine for 5min) using automated oscillometry, and body mass index (BMI) will be calculated from measured height and weight. If participants are suitable to take part with regards to their health questionnaire and BMI measures, a venous blood sample will then be taken to assess full blood count, urea, and electrolytes. Those taking lipid-lowering medication, or who report using nutritional strategies to lower their cholesterol, will be excluded. Participants will be accepted onto the trial if they report habitual consumption of 4-5 portions of red and/or processed meat per week (with 3-4 of these being consumed as main meals), they do not have food allergies related to soya or mycoprotein, and do not demonstrate any clinically significant abnormalities on screening.
Study Protocol; After recruitment, participants will be asked to record all food intake (including snacks and drinks) in a diet diary, for 4 days (3x week or work days, and 1x weekend or rest day) prior to assessment visit 1, for baseline assessment of macronutrient and energy intake. Individuals will be asked to complete further 4-day diet diaries in the week before assessment visits 2,3 and 4 (weeks 4, 10, and 16), to assess any changes in macronutrient or energy intake and meat consumption which may have occurred as a consequence of the intervention. Household measures will be used to estimate portion size, and diaries will be analysed using a food composition database. To calculate habitual diet composition, a mean daily intake will obtained from all 4 days of each recording period, and these data will be combined to produce group means.
Assessment visits will take place in the morning after the individual has fasted from midnight the night before. Initially, measurement of body mass will be made to the nearest 0.1kg using a Seca 882 Digital Scale, and waist and hip circumference will be assessed (with the participant standing) mid-way between the lowest rib and the iliac crest, and at the greater trochanters, respectively. Participants will then be asked to rest, semi-supine, on a couch for >5min before having their resting BP measured, and estimation of body composition made using bioelectrical impedance. A 5ml fasting blood sample will be taken for determination of serum insulin, total cholesterol, high density lipoprotein cholesterol (HDL), low density lipoprotein cholesterol (LDL), triacyl glycerides (TAG) and whole blood glucose. In a subset of the cohort (n=26, 13 Male:13 Female), flow mediated dilatation (FMD) will also be measured on the laboratory visits when fasted, after resting semi-supine for 1 and 2 hours.
Intervention; After visit 1 (week 0) assessment, participants will be asked not to make any changes to their lifestyle and to continue their habitual diet until visit 2 (week 4) when a second assessment will be made ('control' period). The 12 week 'intervention' period will begin on the day after the second study visit. Participants will be given information regarding how meat intake can safely be reduced in their diet, including a recipe book containing ideas for meals using meat analogues and other protein sources. A range of frozen meat-free (soya or mycoprotein 'mince', mycoprotein sausages, meatballs and 'steak strips') and reduced meat products (pork sausages, beef meatballs, beef mince and beef burgers made with 50% meat and 50% soya or mycoprotein) are available for the participants to use to aid this reduction in red meat intake. In addition, a range of dried beans (red kidney, haricot, black turtle), pulses (chick peas, green and red lentils) and grains (quinoa) will also be offered. Weekly telephone contact with the study participants will be maintained over the intervention period to improve compliance, to identify any problems and to arrange further food deliveries.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Notts
-
Nottingham, Notts, Storbritannien, NG72UH
- David Greenfield Human Physiology Unit
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
BMI 18 - 28 kg/m2 Healthy Females should be premenopausal Good spoken and written English Consume 4-5 portions of red and/or processed meat per week consumption of greater than 70g per day
Exclusion Criteria:
Smoking Chronic diseases Hypertension Pregnancy / Breast feeding Chronic medication use (excluding oral contraceptives) Participation in any other research study three months prior to the screening or during study duration Clinically significant findings at screening
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Grundläggande vetenskap
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Inget ingripande: Control
Participants to continue on their habitual diet for 4 weeks
|
|
Experimentell: Meat Reduction
Participants asked to reduce their red and processed meat intake by 50% for 12 weeks
|
Advice, Motivational material and food products provided to participants
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Fasting Serum total cholesterol concentration
Tidsram: Week 0, 4,10 and 16
|
Fasting Serum total cholesterol concentration
|
Week 0, 4,10 and 16
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Fasting Serum LDL cholesterol concentration
Tidsram: Week 0, 4,10 and 16
|
Fasting Serum LDL cholesterol concentration
|
Week 0, 4,10 and 16
|
Fasting Serum HDL cholesterol concentration
Tidsram: Week 0, 4,10 and 16
|
Fasting Serum HDL cholesterol concentration
|
Week 0, 4,10 and 16
|
Fasting whole blood glucose concentration
Tidsram: Week 0, 4,10 and 16
|
Fasting whole blood glucose concentration
|
Week 0, 4,10 and 16
|
Fasting Serum Insulin concentration
Tidsram: Week 0, 4,10 and 16
|
Fasting Serum Insulin concentration
|
Week 0, 4,10 and 16
|
Resting, supine blood pressure
Tidsram: Week 0, 4,10 and 16
|
Resting, supine blood pressure (systolic and diastolic)
|
Week 0, 4,10 and 16
|
Body mass index calculated from measured height and weight (BMI)
Tidsram: Week 0, 4,10 and 16
|
Body mass index calculated from measured height and weight (BMI)
|
Week 0, 4,10 and 16
|
% body fat determined by Bio-electrical Impedance
Tidsram: Week 0, 4,10 and 16
|
% body fat determined by Bio-electrical Impedance
|
Week 0, 4,10 and 16
|
Flow-mediated dilatation
Tidsram: Week 0, 4 and 16
|
Flow mediated dilatation at the brachial artery, measured using ultrasound (in a subset of participants)
|
Week 0, 4 and 16
|
Quality of Life Questionnaire
Tidsram: Week 0, 4,10 and 16
|
WHOQOL Questionnaire
|
Week 0, 4,10 and 16
|
Dietary macro-nutrient intake
Tidsram: Week 0, 4,10 and 16
|
Macro-nutrient intake of the diet determined from diet diaries
|
Week 0, 4,10 and 16
|
Dietary energy intake
Tidsram: Week 0, 4,10 and 16
|
Energy intake of the diet determined from diet diaries
|
Week 0, 4,10 and 16
|
Meat intake
Tidsram: Week 0, 4,10 and 16
|
daily red and processed meat intake determined from diet diaries
|
Week 0, 4,10 and 16
|
Full blood count
Tidsram: Week 0,10 and 16
|
blood cell count, including haemoglobin
|
Week 0,10 and 16
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Andrew Salter, PhD, University of Nottingham
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- TS/L005891/1
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Lipidemi
-
Unity Health TorontoUniversity of Toronto; Kellogg CompanyAvslutadFriska | Lipidemi
-
University of ThessalyAvslutad
-
University Hospital, Gentofte, CopenhagenAktiv, inte rekryterandeHypertriglyceridemiDanmark
-
Imperial College LondonMalaysia Palm Oil BoardAvslutad
-
Herning HospitalSygehus LillebaeltOkänd
-
National University, SingaporeNational University Health System, SingaporeAvslutadPostprandial hyperglykemi | LipidemiSingapore
-
First Affiliated Hospital of Jinan UniversityOkänd
-
Ahmet Murat GünalAvslutadPsylliumberikade hamburgerköttbullar: effekter på postprandial lipidemi, glykemi, aptit och matintagHjärt-kärlsjukdomar | Fetma | Matpreferenser | Appetitivt beteende | Näring, hälsosamKalkon
-
Chun-Hsiang WangOkändStörningar i lipoproteinmetabolism och andra lipidemierTaiwan
-
NewAmsterdam PharmaHar inte rekryterat ännuKranskärlssjukdom | Plack, aterosklerotisk | Lipidemi
Kliniska prövningar på Meat reduction
-
University of California, DavisRockefeller UniversityAvslutad
-
Stanford UniversityUniversity of Colorado, Denver; University of South Florida; Indiana UniversityAvslutadTyp 1-diabetes mellitusFörenta staterna
-
Ball State UniversityRekrytering
-
Wake Forest University Health SciencesHar inte rekryterat ännu
-
Ponce Medical School Foundation, Inc.National Institute of Mental Health (NIMH)RekryteringStigmatisering | Klinisk kompetensFörenta staterna, Puerto Rico
-
Xuanwu Hospital, BeijingThe Second Hospital of Hebei Medical University; The First Affiliated Hospital... och andra samarbetspartnersOkändBasilarinvagination associerad med atlantoaxiell dislokationKina
-
Sheba Medical CenterAvslutadÄrftligt bröst- och äggstockscancersyndromIsrael
-
Cedars-Sinai Medical CenterBayer; Samsung; AppliedVR Inc.; Travelers; Hollywog, LLCAvslutadSmärta, Akut | Smärta, kroniskFörenta staterna
-
Veterans Medical Research FoundationUnited States Department of Defense; Brown University; Seattle Institute... och andra samarbetspartnersRekryteringPosttraumatiska stressyndrom | Skuld | SkamFörenta staterna
-
Universidad Rey Juan CarlosRekryteringMolar, tredje | Periodontal fickaSpanien